What Do We Know About Q Fever in Mexico?

Total Page:16

File Type:pdf, Size:1020Kb

What Do We Know About Q Fever in Mexico? ARTÍCULO ORIGINAL What do we know about Q fever in Mexico? Javier Araujo-Meléndez,* José Sifuentes-Osornio,* J. Miriam Bobadilla-del-Valle,* Antonio Aguilar-Cruz,** Orestes Torres-Ángeles,** José L. Ramírez-González,*** Alfredo Ponce-de-León,* Guillermo M. Ruiz-Palacios,* M. Lourdes Guerrero-Almeida* * Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. ** Jurisdicción Sanitaria No. 4, Huichapan, Hidalgo. *** Hospital General, Huichapan, Hidalgo. ABSTRACT ¿Qué sabemos acerca de la fiebre Q en México? In Mexico, Q fever is considered a rare disease among hu- RESUMEN mans and animals. From March to May of 2008, three pa- tients were referred, from the state of Hidalgo to a En México la fiebre Q se considera una enfermedad rara en- tertiary-care center in Mexico City, with an acute febrile ill- tre los humanos y los animales. Sin embargo, entre marzo y ness that was diagnosed as Q fever. We decided to undertake a mayo 2008 tres pacientes del estado de Hidalgo fueron refe- cross sectional pilot study to identify cases of acute disease in ridos a un hospital de tercer nivel en la Ciudad de México this particular region and to determine the seroprevalence of por una enfermedad febril aguda y fueron diagnosticados Coxiella burnetii among healthy individuals with known risk con fiebre Q. Se decidió llevar a cabo un estudio piloto para factors for infection with this bacteria. Q fever was defined identificar casos de enfermedad aguda en esa región y deter- according to the Centers for Disease Control and Prevention minar la prevalencia serológica de Coxiella burnetii en indi- criteria. All subjects were interviewed for signs and symptoms viduos sanos con factores de riesgo conocidos. Se definió of the disease, demographic and household characteristics and fiebre Q conforme a los criterios de los Centros de Control y occupational exposure to cattle. Blood samples were taken Prevención de Enfermedades (CDC). Todos los sujetos en es- from hospitalized and outpatients with symptoms suggestive tudio fueron entrevistados para detectar signos y síntomas of Q fever, as well as from asymptomatic individuals with di- de la enfermedad, características demográficas y de la vi- rect and daily exposure to cattle (slaughterers, butchers, far- vienda y exposición ocupacional a ganado. Se tomaron mues- mers, shepherds and veterinarians) in the five municipalities. tras sanguíneas a los pacientes hospitalizados y externos con We report the occurrence of 17 cases with positive antibodies síntomas sugerentes de fiebre Q, así como a individuos asin- against C. burnetii in a rural area of central Mexico; eight ca- tomáticos con exposición directa y cotidiana con ganado ses had clinical criteria of acute Q fever disease. Results from (granjeros, carniceros, pastores y veterinarios). Se reporta- this pilot study underscore the need for active surveillance ron 17 casos con anticuerpos positivos contra C. burnetii en programs and comprehensive studies to further define the esta área rural; ocho casos cumplieron con los criterios de prevalence and risk factors associated with the disease in enfermedad aguda. Los resultados subrayan la necesidad Mexico, to know more about its clinical presentation and to de llevar a cabo programas de vigilancia activa y la realización characterize bacterial factors involved in its pathogenesis. de estudios prospectivos poblacionales para definir la preva- lencia y factores de riesgo de la enfermedad en México, así como para caracterizar mejor la presentación clínica y los factores asociados con la patogenicidad de la bacteria. Key words. Q fever. Coxiella burnetii. Exotic diseases in Palabras clave. Fiebre Q. Coxiella burnetii. Enfermedades Mexico. Infections in the rural area. Zoonosis. exóticas en México. Infecciones en el área rural. Zoonosis. INTRODUCTION in milk, urine and feces of infected animals and most importantly, during birthing the bacteria is Q fever is a zoonotic disease caused by Coxiella shed in high numbers within the amniotic fluids burnetii, a species of bacteria with a worldwide dis- and the placenta. The organisms are resistant to tribution.1 The primary reservoirs of C. burnetii heat, drying and many common disinfectants, fea- are cattle, sheep and goats. C. burnetii is excreted tures that enable the bacteria to survive for long Revistai de Investigación gac Clínicaíni / Vol. 64, Núm. 6 (Parte I) / Noviembre-Diciembre, 2012 / pp 541-545 periods in the environment. Infection of humans in the five municipalities. Serologic assessment for usually occurs after inhalation of aerosols from specific antiphase II C. burnetii antigen type IgG an- contaminated barnyards dust, excreta and direct tibodies was performed using an ELISA test (Phase contact with birth fluids of infected herd animals. IIIgG, Virion/Serion®, Würzbur, Germany); positive The disease has also been described in abattoir results were confirmed using an indirect immu- workers.2 Only about 40% of all people infected nofluorescence assay (IFA) (BioMerieux®, Marcy with C. burnetii develop clinical disease and in cer- l’Etoile, France). Infection with C. burnetii was con- tain risk groups (immunocompromised hosts) the sidered positive by either an antiphase II C. burnetii infection (symptomatic or not) may result in chro- antigen IgG titer > 200 IU/mL or antiphase II C. nic disease (2% of cases).3-5 burnetii antigen IgM titer > 50 IU/mL in a single Since 1994, Q fever is a notifiable disease in Mexi- serum sample. Statistical analyses were performed co.6 Due to the lack of specific signs and symptoms using the STATA software® version 8:0 (College and to the difficulties of making an accurate diagno- Station, Texas, USA). Measures of central tendency sis without appropriate laboratory testing, Q fever and dispersion, frequency and proportions, chi-squa- is underreported and it is commonly referred as a re test or Fisher’s exact test were used as appro- rare, exotic disease in both, humans and animals. priate to describe the data and to determine the Interestingly, the seroprevalence of Q fever reported significance of associations between study variables. in the United States during the National Health and Odds ratios and corresponding 95% Confidence In- Nutrition Examination Survey (NHANES 2003- tervals (95% CI) were calculated using logistic re- 2004), was higher for subjects of Mexican-American gression methods. A two-tailed p value ≤ 0.05 was origin than that reported in the non-Hispanic Ame- considered as statistically significant. The Institu- rican populations. This study suggested differences tional Review Board approved the study, and all sub- in geographical or occupational exposure, but we jects signed informed consent. could not identify the source of the infection.7 RESULTS MATERIAL AND METHODS A total of 159 subjects were included in the study From March to May 2008, three patients were re- (Figure 1). Twenty three subjects reported a history ferred to this tertiary-care hospital located in Mexi- of prolonged fever during the prior year or presen- co City, with persistent high fever, chills, malaise ted with acute symptoms: the three initial sympto- and mild hepatitis. Serologic assessment of the three matic patients, five more cases of acute Q fever patients revealed positive antibodies against C. bur- detected during the study and three of 15 subjects netii and in two, a liver biopsy showed the classical with a history of prolonged fever had > 200 IU/mL granulomatous hepatitis. All of them were residents titers of anti-phase II C. burnetii antigen IgG anti- of a farming region in the state of Hidalgo, Mexico. bodies. Among the 136 asymptomatic subjects, 6 We decided to undertake a cross sectional pilot study (4.4%) subjects were infected, and 3 of them had se- to identify cases of acute disease in this particular rologic evidence of acute infection with C. burnetii region and to determine the seroprevalence of C. (specific IgG antibody titers ≥ 1:256 by IFA). The burnetii among healthy individuals with known risk median age of the 8 acutely ill subjects was 44 years, factors for infection with this bacteria. From June all had acute fever, chills, headache, fatigue, myal- through August 2009, this pilot study was conduc- gias and arthralgias; mild hepatitis was detected in ted in collaboration with the jurisdictional health 6 cases, and only 3 had daily exposure to cattle. authorities of five municipalities in the state of Hi- None developed pneumonia, endocarditis or endovascu- dalgo. Q fever was defined according to the Centers lar infections. All patients with suspected or confir- for Disease Control and Prevention (CDC) criteria.8 med diagnosis of Q fever were treated and all had All subjects were interviewed for signs and complete resolution of symptoms. Table 1 shows the symptoms of the disease, demographic and house- demographic characteristics and antibody titers of hold characteristics and occupational exposure to the 17 (10.7%) subjects with confirmed C. burnetii cattle. Blood samples were taken from hospitalized infection. and outpatients with symptoms suggestive of Q fe- Univariate analysis including the 159 subjects in ver, as well as from asymptomatic individuals with the study showed that male gender (OR 6.2, 95% CI: direct and daily exposure to cattle (slaughterers, 0.8 to 48.88, p = 0.08) and living in Huichapan/Te- butchers, farmers, shepherds and veterinarians) cozautla (OR 6.7; 95% CI: 1.47, 30.38, p = 0.014), 542 Araujo-Meléndez J, et al. Q fever in Mexico. Rev Investes ClinC 2012; 64 (6) Parte I: 541-545 159 subjects included 23 subjects with symptoms 136 subjects without or history of prolonged fever during the prior year symptoms during the prior year ELISA (+) ELISA (-) 6 subjects (4.4%) 130 subjects (95.6%) History of Clinical suspicion of Q fever 15 subjects fever and ELISA (+) 8 patients ELISA (+) ELISA (-) 3 subjects 12 subjects 3 patients were 5 patients diagnosed hospitalized during the study Figureg e 1. Population included in the study and prevalence of infection by Coxiella burnetii: 159 subjects were included in the study, 23 reported a current or previous history of fever and 136 more asymptomatic.
Recommended publications
  • CD Alert Monthly Newsletter of National Centre for Disease Control, Directorate General of Health Services, Government of India
    CD Alert Monthly Newsletter of National Centre for Disease Control, Directorate General of Health Services, Government of India May - July 2009 Vol. 13 : No. 1 SCRUB TYPHUS & OTHER RICKETTSIOSES it lacks lipopolysaccharide and peptidoglycan RICKETTSIAL DISEASES and does not have an outer slime layer. It is These are the diseases caused by rickettsiae endowed with a major surface protein (56kDa) which are small, gram negative bacilli adapted and some minor surface protein (110, 80, 46, to obligate intracellular parasitism, and 43, 39, 35, 25 and 25kDa). There are transmitted by arthropod vectors. These considerable differences in virulence and organisms are primarily parasites of arthropods antigen composition among individual strains such as lice, fleas, ticks and mites, in which of O.tsutsugamushi. O.tsutsugamushi has they are found in the alimentary canal. In many serotypes (Karp, Gillian, Kato and vertebrates, including humans, they infect the Kawazaki). vascular endothelium and reticuloendothelial GLOBAL SCENARIO cells. Commonly known rickettsial disease is Scrub Typhus. Geographic distribution of the disease occurs within an area of about 13 million km2 including- The family Rickettsiaeceae currently comprises Afghanistan and Pakistan to the west; Russia of three genera – Rickettsia, Orientia and to the north; Korea and Japan to the northeast; Ehrlichia which appear to have descended Indonesia, Papua New Guinea, and northern from a common ancestor. Former members Australia to the south; and some smaller of the family, Coxiella burnetii, which causes islands in the western Pacific. It was Q fever and Rochalimaea quintana causing first observed in Japan where it was found to trench fever have been excluded because the be transmitted by mites.
    [Show full text]
  • WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T (51) International Patent Classification: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, A61K 31/197 (2006.01) A61K 45/06 (2006.01) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, A61K 31/60 (2006.01) A61P 31/00 (2006.01) TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, A61K 33/22 (2006.01) ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/IN20 12/000634 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (22) International Filing Date UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 24 September 2012 (24.09.2012) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Language: English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: ML, MR, NE, SN, TD, TG). 2792/DEL/201 1 23 September 201 1 (23.09.201 1) IN Declarations under Rule 4.17 : (72) Inventor; and — of inventorship (Rule 4.17(iv)) (71) Applicant : CHAUDHARY, Manu [IN/IN]; 51-52, In dustrial Area Phase- 1, Panchkula 1341 13 (IN).
    [Show full text]
  • Overview of Fever of Unknown Origin in Adult and Paediatric Patients L
    Overview of fever of unknown origin in adult and paediatric patients L. Attard1, M. Tadolini1, D.U. De Rose2, M. Cattalini2 1Infectious Diseases Unit, Department ABSTRACT been proposed, including removing the of Medical and Surgical Sciences, Alma Fever of unknown origin (FUO) can requirement for in-hospital evaluation Mater Studiorum University of Bologna; be caused by a wide group of dis- due to an increased sophistication of 2Paediatric Clinic, University of Brescia eases, and can include both benign outpatient evaluation. Expansion of the and ASST Spedali Civili di Brescia, Italy. and serious conditions. Since the first definition has also been suggested to Luciano Attard, MD definition of FUO in the early 1960s, include sub-categories of FUO. In par- Marina Tadolini, MD Domenico Umberto De Rose, MD several updates to the definition, di- ticular, in 1991 Durak and Street re-de- Marco Cattalini, MD agnostic and therapeutic approaches fined FUO into four categories: classic Please address correspondence to: have been proposed. This review out- FUO; nosocomial FUO; neutropenic Marina Tadolini, MD, lines a case report of an elderly Ital- FUO; and human immunodeficiency Via Massarenti 11, ian male patient with high fever and virus (HIV)-associated FUO, and pro- 40138 Bologna, Italy. migrating arthralgia who underwent posed three outpatient visits and re- E-mail: [email protected] many procedures and treatments before lated investigations as an alternative to Received on November 27, 2017, accepted a final diagnosis of Adult-onset Still’s “1 week of hospitalisation” (5). on December, 7, 2017. disease was achieved. This case report In 1997, Arnow and Flaherty updated Clin Exp Rheumatol 2018; 36 (Suppl.
    [Show full text]
  • Endocarditis Due to Bartonella Quintana, the Etiological Agent of Trench Fever
    PRACTICE | CASES CPD VULNERABLE POPULATIONS Endocarditis due to Bartonella quintana, the etiological agent of trench fever Carl Boodman MD, Terence Wuerz MD MSc (Epi), Philippe Lagacé-Wiens MD n Cite as: CMAJ 2020 December 7;192:E1723-6. doi: 10.1503/cmaj.201170 CMAJ Podcasts: author interview at www.cmaj.ca/lookup/doi/10.1503/cmaj.201170/tab-related-content 48-year-old man presented to the emergency depart- ment with a 2-day history of pleuritic chest pain and KEY POINTS shortness of breath. His medical history included HIV • Bartonella quintana, the causal agent of trench fever, is infection,A diagnosed 14 years earlier in the context of intraven- transmitted by body lice (Pediculus humanus var. corporis). ous drug use. Three months previously, he had an undetectable • Although B. quintana is notorious for causing disease in the First viral load and a CD4 count of 94 cells/mm3 (normal range: 500– World War, outbreaks of trench fever have recently occurred in 1400 cells/mm3) or 0.09 (normal range 0.50–1.40) × 109/L. The urban populations experiencing homelessness. patient adhered to his prescribed antiretroviral regimen (darunavir, • B. quintana causes culture-negative endocarditis and may be ritonavir and abacavir-lamivudine) and prophylaxis against oppor- fatal without antimicrobial and surgical treatment, despite mild tunistic infections (valacyclovir, trimethoprim-sulfamethoxazole symptomatology during chronic bacteremia. Consultation with infectious disease specialists is encouraged. and fluconazole). In addition, the patient had a congenital soli- Because B. quintana evades identification in routine blood tary kidney with normal baseline renal function, alcohol expos- • cultures, diagnosis of B.
    [Show full text]
  • TYPHUS FEVERS Typhus 2
    57 Feb., 1949 j EDITORIAL nostic titre is 1 in 1(30 but a rise in titre from 1 in 20 or 1 in 1 is significant (Rivers, loc. cit.). Indian Medical Gazette Even a titre of 1 in 100 may be accepted (War Office, loc. cit.). (8) Para-amino-benzoic acid given in the first week of the disease has a favourable influence on the course of the disease. DDT will kill all lice' on a FEBRUARY (9) dusting powder patient. The dusting is repeated after a week. (10) A subject recovered from classical typhus is immune to the murine and vice versa. TYPHUS FEVERS typhus 2. Murine causal is While the classical fever is now a typhus.?Its agent typhus R. mooseri which is borne the matter of almost ancient in medicine, by rat-flea, history same which other forms of this of fevers have been Xenopsylla cheopis (the spccics group The are endemic within the last 20 or so. fhe carries plague). synonyms recognized years urban of latest information about the latter was obtained typhus, typhus, shop typhus Malaya, flea and rat typhus : there arc at least during the World War II only. It was of typhus 6 names. military importance and remained a hush-hush affair so far as the general, non-service, medical The causal agent is capable of causing an after a few human profession was concerned. Details have been epidemic passages through lice from released only recently and have appeared in and is serologically indistinguishable serum of books (War Office, 1946; Rivers, 1948; Stitt, R.
    [Show full text]
  • Recurrent Fever in Children
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by AIR Universita degli studi di Milano International Journal of Molecular Sciences Review Recurrent Fever in Children Sofia Torreggiani 1, Giovanni Filocamo 1 and Susanna Esposito 2,* 1 Pediatric Medium Intensive Care Unit, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; sofi[email protected] (S.T.); giovanni.fi[email protected] (G.F.) 2 Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy * Correspondence: [email protected]; Tel.: +39-02-5503-2498; Fax: +39-02-5032-0206 Academic Editor: Vera Sau-Fong Chan Received: 3 February 2016; Accepted: 21 March 2016; Published: 25 March 2016 Abstract: Children presenting with recurrent fever may represent a diagnostic challenge. After excluding the most common etiologies, which include the consecutive occurrence of independent uncomplicated infections, a wide range of possible causes are considered. This article summarizes infectious and noninfectious causes of recurrent fever in pediatric patients. We highlight that, when investigating recurrent fever, it is important to consider age at onset, family history, duration of febrile episodes, length of interval between episodes, associated symptoms and response to treatment. Additionally, information regarding travel history and exposure to animals is helpful, especially with regard to infections. With the exclusion of repeated independent uncomplicated infections, many infective causes of recurrent fever are relatively rare in Western countries; therefore, clinicians should be attuned to suggestive case history data.
    [Show full text]
  • Circulatory and Lymphatic System Infections 1105
    Chapter 25 | Circulatory and Lymphatic System Infections 1105 Chapter 25 Circulatory and Lymphatic System Infections Figure 25.1 Yellow fever is a viral hemorrhagic disease that can cause liver damage, resulting in jaundice (left) as well as serious and sometimes fatal complications. The virus that causes yellow fever is transmitted through the bite of a biological vector, the Aedes aegypti mosquito (right). (credit left: modification of work by Centers for Disease Control and Prevention; credit right: modification of work by James Gathany, Centers for Disease Control and Prevention) Chapter Outline 25.1 Anatomy of the Circulatory and Lymphatic Systems 25.2 Bacterial Infections of the Circulatory and Lymphatic Systems 25.3 Viral Infections of the Circulatory and Lymphatic Systems 25.4 Parasitic Infections of the Circulatory and Lymphatic Systems Introduction Yellow fever was once common in the southeastern US, with annual outbreaks of more than 25,000 infections in New Orleans in the mid-1800s.[1] In the early 20th century, efforts to eradicate the virus that causes yellow fever were successful thanks to vaccination programs and effective control (mainly through the insecticide dichlorodiphenyltrichloroethane [DDT]) of Aedes aegypti, the mosquito that serves as a vector. Today, the virus has been largely eradicated in North America. Elsewhere, efforts to contain yellow fever have been less successful. Despite mass vaccination campaigns in some regions, the risk for yellow fever epidemics is rising in dense urban cities in Africa and South America.[2] In an increasingly globalized society, yellow fever could easily make a comeback in North America, where A. aegypti is still present.
    [Show full text]
  • Human Louse-Transmitted Infectious Diseases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REVIEW 10.1111/j.1469-0691.2012.03778.x Human louse-transmitted infectious diseases S. Badiaga1,2 and P. Brouqui1 1) URMITE, CNRS-IRD, UMR 6236/198, Poˆle des Maladies Infectieuses AP-HM, Institut Hospitalo-Universitaire Me´diterrane´e Infection and 2) Service d’Accueil des Urgences Adultes, Poˆle AUR, CHU hoˆpital Nord, Marseille, France Abstract Several of the infectious diseases associated with human lice are life-threatening, including epidemic typhus, relapsing fever, and trench fever, which are caused by Rickettsia prowazekii, Borrelia recurrentis, and Bartonella quintana, respectively. Although these diseases have been known for several centuries, they remain a major public health concern in populations living in poor-hygiene conditions because of war, social disruption, severe poverty, or gaps in public health management. Poor-hygiene conditions favour a higher prevalence of body lice, which are the main vectors for these diseases. Trench fever has been reported in both developing and developed countries in pop- ulations living in poor conditions, such as homeless individuals. In contrast, outbreaks of epidemic typhus and epidemic relapsing fever have occurred in jails and refugee camps in developing countries. However, reports of a significantly high seroprevalence for epidemic typhus and epidemic relapsing fever in the homeless populations of developed countries suggest that these populations remain at high risk for outbreaks of these diseases. Additionally, experimental laboratory studies have demonstrated that the body louse can transmit other emerging or re-emerging pathogens, such as Acinetobacter baumannii and Yersinia pestis.
    [Show full text]
  • Epidemic Typhus: a Re-Emerging Rickettsial Zoonosis
    ACTA SCIENTIFIC MICROBIOLOGY (ISSN: 2581-3226) Volume 2 Issue 9 September 2019 Review Article Epidemic Typhus: A Re-Emerging Rickettsial Zoonosis Mahendra Pal1* and Pratibha Dave2 1Narayan Consultancy on Veterinary Public Health and Microbiology, Aangan, Gujarat, India 2Welfare Hospital and Research Centre, Gujarat, India *Corresponding Author: Founder of Narayan Consultancy on Veterinary Public Health and Microbiology, Aangan, Gujarat, India. Received: July 29, 2019; Published: August 16, 2019 DOI: 10.31080/ASMI.2019.02.0344 Abstract Epidemic typhus is a re-emerging zoonosis of public health concern, and is caused by Rickettsia prowazekii that is considered a bioterrorism agent. In earlier centuries, epidemic typhus was responsible for millions of deaths in several parts of the world. The disease is transmitted through infected feces of the body louse, and is responsible for great epidemics in people who live in over- crowded and unhygienic conditions. Outbreaks of louse borne epidemic typhus are recorded in several countries, such as Burundi, Ethiopia, Nigeria, Peru, Rwanda and Uganda. The primary clinical manifestations of disease include fever, headache, and rash. Clinical illness. Presently, doxycycline is considered the mainstay of treatment. The mortality rate in severe cases without antibiotic therapy diagnosis should be supported with laboratory findings and needs to be differentiated from other diseases, which present febrile patient. The public should be educated to avoid visiting crowded areas, avoid sharing clothes, taking daily bath, and maintaining hy- may reach up to 60%. It is imperative to make an early diagnosis to start a prompt specific therapy to mitigate the suffering of the gienic conditions at home. It is advised that delayed diagnosis and treatment should be avoided as it may lead to increase morbidity and mortality.
    [Show full text]
  • Human Bartonellosis: an Underappreciated Public Health Problem?
    Tropical Medicine and Infectious Disease Review Human Bartonellosis: An Underappreciated Public Health Problem? Mercedes A. Cheslock and Monica E. Embers * Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA 70433, USA; [email protected] * Correspondence: [email protected]; Tel.: +(985)-871-6607 Received: 24 March 2019; Accepted: 16 April 2019; Published: 19 April 2019 Abstract: Bartonella spp. bacteria can be found around the globe and are the causative agents of multiple human diseases. The most well-known infection is called cat-scratch disease, which causes mild lymphadenopathy and fever. As our knowledge of these bacteria grows, new presentations of the disease have been recognized, with serious manifestations. Not only has more severe disease been associated with these bacteria but also Bartonella species have been discovered in a wide range of mammals, and the pathogens’ DNA can be found in multiple vectors. This review will focus on some common mammalian reservoirs as well as the suspected vectors in relation to the disease transmission and prevalence. Understanding the complex interactions between these bacteria, their vectors, and their reservoirs, as well as the breadth of infection by Bartonella around the world will help to assess the impact of Bartonellosis on public health. Keywords: Bartonella; vector; bartonellosis; ticks; fleas; domestic animals; human 1. Introduction Several Bartonella spp. have been linked to emerging and reemerging human diseases (Table1)[ 1–5]. These fastidious, gram-negative bacteria cause the clinically complex disease known as Bartonellosis. Historically, the most common causative agents for human disease have been Bartonella bacilliformis, Bartonella quintana, and Bartonella henselae.
    [Show full text]
  • A Mixed Outbreak of Epidemic Typhus Fever and Trench Fever in a Youth Rehabilitation Center: Risk Factors for Illness from a Case-Control Study, Rwanda, 2012
    Am. J. Trop. Med. Hyg., 95(2), 2016, pp. 452–456 doi:10.4269/ajtmh.15-0643 Copyright © 2016 by The American Society of Tropical Medicine and Hygiene A Mixed Outbreak of Epidemic Typhus Fever and Trench Fever in a Youth Rehabilitation Center: Risk Factors for Illness from a Case-Control Study, Rwanda, 2012 Irenee Umulisa,1* Jared Omolo,2 Katherine A. Muldoon,3,4 Jeanine Condo,5 Francois Habiyaremye,1 Jean Marie Uwimana,1 Marie Aimee Muhimpundu,6 Tura Galgalo,2 Samuel Rwunganira,1,6 Anicet G. Dahourou,2 Eric Tongren,7 Jean Baptiste Koama,8 Jennifer McQuiston,9 Pratima L. Raghunathan,8 Robert Massung,9 Wangeci Gatei,8 Kimberly Boer,8 Thierry Nyatanyi,6 Edward J. Mills,3,4,10 and Agnes Binagwaho11,12,13 1Rwanda Field Epidemiology and Laboratory Training Program, School of Public Health, University of Rwanda, Kigali, Rwanda; 2CTS Global assigned to U.S. Centers for Disease Control and Prevention, Kigali, Rwanda; 3University of British Columbia, Vancouver, Canada; 4University of Ottawa, Ottawa, Canada; 5School of Public Health, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; 6Epidemic Infectious Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda; 7Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. Centers for Disease Control and Prevention, Kigali, Rwanda; 8Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control and Prevention, Kigali, Rwanda; 9National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; 10Stanford University, Stanford, California; 11Ministry of Health Rwanda, Kigali, Rwanda; 12Harvard Medical School, Boston, Massachusetts; 13Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
    [Show full text]
  • Tropical Fevers: Part A. Viral, Bacterial, and Fungal
    5A.1 CHAPTER 5 Tropical Fevers: Part A. Viral, bacterial, and fungal John Frean and Lucille Blumberg 1. INTRODUCTION Pyrexial illness is a presentation of many diseases particularly associated with tropical environments, but one should remember that many common infections, such as influenza and tuberculosis, also occur in the tropics or may be acquired en route to and from exotic locales. Febrile patients may also have chronic or recurrent medical problems that are unrelated to their tropical exposure, including non-infectious disease e.g. autoimmune or malignant conditions. In approaching a pyrexial patient, therefore, a general medical history should aim to elicit the presence of any underlying conditions, particularly those associated with increased risk of infections such as diabetes, neoplastic conditions, HIV infection, splenectomy, and pregnancy. The history of the current illness will determine the duration (acute or chronic) and pattern, if any, of fever; signs and symptoms which may be important in suggesting possible aetiologies are headache and other central nervous system involvement; myalgia and arthralgia; photophobia and conjunctivitis; skin rashes and localised lesions; lymphadenopathy, hepatomegaly, and splenomegaly; jaundice, and anaemia. The geographic and travel history, both recent and past, is of course of vital importance. The onset of illness in relation to known incubation periods and time of possible exposure can help to include or eliminate various infectious diseases (see Table 1). The areas visited and the nature of the travel may also be helpful in suggesting the likely exposures, e.g. business travel confined to city hotels has a different risk profile compared to river-rafting adventures.
    [Show full text]